FindTrial
Sign In

A Single Arm Clinical Study to evaluate the efficacy of Shigrumooladi lepa in the management of raktarsha with special reference to 1st and 2nd degree hemorrhoids.

A Single Arm Clinical Study to evaluate the efficacy of Shigrumooladi lepa in the management of raktarsha with special reference to 1st and 2nd degree hemorrhoids. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098505
Enrollment
30
Registered
2025-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids Health Condition 2: K640- First degree hemorrhoids

Interventions

None listed

Sponsors

Jeevan Jyoti Ayurvedic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: DIAGNOSED PATIENTS OF RAKTASRAVA-ANAL BLEED PATIENTS OF EITHER SEX PATIENTS WITH CONTROLLED HYPERTENSION AND DIABETES MELLITUS FRESH OR PREVIOUSLY OPERATED PAINFULL OR PAINLESS

Exclusion criteria

Exclusion criteria: Patients suffering from Bleeding disorders like-Anal polyp ,prolapsed rectum ,Ulcerative colitis ,Crohn s Disease ,Carcinoma of rectum and anus . Infectious diseases like HIV ,HbsAg ,HCV Pregnant and lactating women Incontinence of stool Bleeding diathesis

Design outcomes

Primary

MeasureTime frame
Reduction in per-rectal bleeding (Raktasrava). Timepoint: 4 weeks—

Secondary

MeasureTime frame
Improvement in quality of life (QoL) Reduction in associated symptoms such as constipation, pruritus ano,etcTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Yati Tiwari

Jeevan Jyoti Ayurvedic Medical College and Hospital,Aligarh

Yati_tiwari@yahoo.com8445733813

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026